Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Medientyp: E-Artikel

Titel: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Beteiligte: Bisceglia, Irma; Canale, Maria Laura; Gallucci, Giuseppina; Turazza, Fabio Maria; Lestuzzi, Chiara; Parrini, Iris; Russo, Giulia; Maurea, Nicola; Quagliariello, Vincenzo; Oliva, Stefano; Di Fusco, Stefania Angela; Lucà, Fabiana; Tarantini, Luigi; Trambaiolo, Paolo; Moreo, Antonella; Geraci, Giovanna; Gabrielli, Domenico; Gulizia, Michele Massimo; Oliva, Fabrizio; Colivicchi, Furio

Erschienen: Frontiers Media SA, 2022

Sprache: Nicht zu entscheiden

DOI: 10.3389/fcvm.2022.821193

ISSN: 2297-055X

Schlagwörter: Cardiology and Cardiovascular Medicine

Entstehung:

Anmerkungen:

Beschreibung: The pathophysiology of some non-communicable diseases (NCDs) such as hypertension, cardiovascular disease (CVD), diabetes, and cancer includes an alteration of the endothelial function. COVID-19 is a pulmonary and vascular disease with a negative impact on patients whose damaged endothelium is particularly vulnerable. The peculiar SARS-CoV-2-induced “endothelitis” triggers an intriguing immune-thrombosis that affects both the venous and arterial vascular beds. An increased liability for infection and an increased likelihood of a worse outcome have been observed during the pandemic in patients with active cancer and in cancer survivors. “Overlapping commonalities” between COVID-19 and Cardio-Oncology have been described that include shared phenotypes of cardiovascular toxicities such as left ventricular dysfunction, ischemic syndromes, conduction disturbances, myocarditis, pericarditis and right ventricular failure; shared pathophysiologic mechanisms such as inflammation, release of cytokines, the renin-angiotensin-aldosterone-pathway, coagulation abnormalities, microthrombosis and endothelial dysfunction. For these features and for the catalyst role of NCDs (mainly CVD and cancer), we should refer to COVID-19 as a “syndemic.” Another challenging issue is the persistence of the symptoms, the so-called “long COVID” whose pathogenesis is still uncertain: it may be due to persistent multi-organ viral attacks or to an abnormal immune response. An intensive vaccination campaign is the most successful pharmacological weapon against SARS-CoV-2, but the increasing number of variants has reduced the efficacy of the vaccines in controlling SARS-CoV-2 infections. After a year of vaccinations we have also learned more about efficacy and side-effects of COVID-19 vaccines. An important byproduct of the COVID-19 pandemic has been the rapid expansion of telemedicine platforms across different care settings; this new modality of monitoring cancer patients may be useful even in a post pandemic era. In this paper we analyze the problems that the cardio-oncologists are facing in a pandemic scenario modified by the extensive vaccination campaign and add actionable recommendations derived from the ongoing studies and from the syndemic nature of the infection.

Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: